The AI precision medical platform company Caris Life Sciences (CAI.US) applies for a US stock IPO with a planned fundraising of up to $300 million.

date
24/05/2025
According to the Wisdom Financial APP, Caris Life Sciences Inc. (CAI.US), a medical company specializing in cancer diagnosis and treatment technology, submitted its initial public offering (IPO) application to the U.S. Securities and Exchange Commission (SEC) on Friday, aiming to raise up to $300 million.
Latest
See all latestmore